TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
LobSor Pharmaceuticals AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
86,393
|
12,465
|
37,569 |
| Financial expenses |
0
|
13
|
103 |
| Earnings before taxes |
79,159
|
36,677
|
47,835 |
| EBITDA |
76,340
|
35,991
|
56,960 |
| Total assets |
186,402
|
106,968
|
73,860 |
| Current assets |
154,778
|
73,048
|
33,658 |
| Current liabilities |
91,265
|
16,667
|
759 |
| Equity capital |
95,137
|
90,301
|
73,101 |
| - share capital |
44
|
50
|
50 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
51.0%
|
84.4%
|
99.0% |
| Turnover per employee |
28,798
|
4,155
|
12,523 |
| Profit as a percentage of turnover |
91.6%
|
294.2%
|
127.3% |
| Return on assets (ROA) |
42.5%
|
34.3%
|
64.9% |
| Current ratio |
169.6%
|
438.3%
|
4434.5% |
| Return on equity (ROE) |
83.2%
|
40.6%
|
65.4% |
| Change turnover |
73,928
|
-25,104
|
12,113 |
| Change turnover % |
593%
|
-67%
|
48% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
200% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.